Medicare Enrolled

Dr. Sarah Tadros, MPAP

Physician Assistant · Montclair, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
9301 CENTRAL AVE, Montclair, CA 91763
9096215005
In practice since 2016 (9 years)
NPI: 1588118921 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Tadros from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tadros? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Tadros

Dr. Sarah Tadros is a physician assistant in Montclair, CA, with 9 years of NPI registration. Based on federal Medicare data, Dr. Tadros performed 872 Medicare services across 518 unique beneficiaries.

Between the years covered by Open Payments, Dr. Tadros received a total of $1,374 from 18 pharmaceutical and/or device companies across 57 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Tadros is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 9 years in practice ▲ Top 15% volume in CA $1,374 industry payments

Medicare Practice Summary

Medicare Utilization ↗
872
Medicare services
Top 15% in CA for physician assistant
518
Unique beneficiaries
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~97 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
284 $4 $35
Tissue pathology examination, moderate complexity
A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue.
158 $21 $135
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
104 $56 $110
Destruction of 15 or more precancerous skin growths
This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer.
86 $107 $265
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
82 $33 $100
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
53 $30 $100
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
25 $51 $135
Shaving of skin growth, 1.1-2.0 cm
This procedure involves shaving off a skin growth measuring between 1.1 and 2.0 centimeters from the body, arms, or legs.
24 $76 $125
Removal of noncancer skin growth, 1.1-2.0 cm
This procedure involves the surgical removal of a benign skin growth located on the body, arms, or legs. The growth measured between 1.1 and 2.0 centimeters in diameter.
20 $93 $225
Shaving of skin growth, 0.6-1.0 cm
A minor procedure to shave off a skin growth on the body, arms, or legs that measures between 0.6 and 1.0 centimeters.
18 $57 $107
Shaving of skin growth on face, 0.6-1.0 cm
This procedure involves shaving off a skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the growth being removed is between 0.6 and 1.0 centimeters.
18 $76 $125
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,374
Total received (2021-2024)
Avg $343/year across 4 years
Top 23% in CA for physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
18
Companies
57
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,249 (90.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$125 (9.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$616
2023
$95
2022
$261
2021
$403

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
SUN PHARMACEUTICAL INDUSTRIES INC.
$240
Regeneron Healthcare Solutions, Inc.
$125
PFIZER INC.
$64
E.R. Squibb & Sons, L.L.C.
$42
Amgen Inc.
$29
Janssen Biotech, Inc.
$28
ABBVIE INC.
$20
Novartis Pharmaceuticals Corporation
$18
Verrica Pharmaceuticals Inc.
$17
Galderma Laboratories, L.P.
$17
Lilly USA, LLC
$15
Top 3 companies account for 69.8% of 2024 payments
All-time payments by company (2021-2024) ›
SUN PHARMACEUTICAL INDUSTRIES INC.
$257
Regeneron Healthcare Solutions, Inc.
$180
UCB, Inc.
$149
PFIZER INC.
$125
Lilly USA, LLC
$121
Sun Pharmaceutical Industries Inc.
$81
Novartis Pharmaceuticals Corporation
$80
Janssen Biotech, Inc.
$51
GENZYME CORPORATION
$50
Galderma Laboratories, L.P.
$48
Amgen Inc.
$42
E.R. Squibb & Sons, L.L.C.
$42
ABBVIE INC.
$37
Nabriva Therapeutics, plc
$29
LEO Pharma Inc.
$23
Incyte Corporation
$22
SANOFI-AVENTIS U.S. LLC
$20
Verrica Pharmaceuticals Inc.
$17
Top 3 companies account for 42.7% of all-time payments
Associated products mentioned in payments ›
ADBRY · AKLIEF · CIBINQO · COSENTYX · Cimzia · DUPIXENT · EUCRISA · ILUMYA · Ilumya · OLUMIANT · OPZELURA · ORACEA · Otezla · REMICADE · SKYRIZI · Sivextro · Sotyktu · TALTZ · TREMFYA · Winlevi · YCANTH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (91%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a physician assistant in Montclair?
Compare physician assistants in the Montclair area by procedure volume, costs, and industry payment transparency.
Browse physician assistants nearby

Geographic Context

Physician assistants within 10 mi
1,954
Per 100K population
89.3
County median income
$82,184
Nearest hospital
MONTCLAIR HOSPITAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Tadros is a clinical cardiology specialist, with above-average Medicare volume (top 15% in CA), with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Tadros experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Tadros performed 284 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tadros receive payments from pharmaceutical companies?
Yes. Dr. Tadros received a total of $1,374 from 18 companies across 57 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tadros's costs compare to other physician assistants in Montclair?
Dr. Tadros's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tadros) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →